Anika Therapeutics to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference.WOBURN, Mass. -- Anika Therapeutics, Inc. (Nasdaq:ANIK ANIK Canadian COMSAT ) today said that its Chief Executive Officer Charles H. Sherwood, Ph.D., will present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference to be held May 4-5 at the InterContinental Hotel in Paris, France. Dr. Sherwood will present an overview of the company and discuss current products, product pipeline, growth drivers and recent financial performance. Some of the information to be presented by Dr. Sherwood may contain information that has not been previously disclosed. The presentation will take place Thursday, May 5th, at 4:30 a.m. Eastern and will be open to all interested parties through a live webcast at http://www.wsw.com/webcast/rrshq5/anik/, and on Anika Therapeutics' Web site at http://www.anikatherapeutics.com/investors. Listeners are encouraged to visit the Web site at least 15 minutes prior to the beginning of the scheduled presentation to register and download and install any necessary audio software. The presentation will be archived on the same Web sites and available for a 90-day period. About Anika Therapeutics, Inc. Headquartered in Woburn, Mass., Anika Therapeutics, Inc. (www.anikatherapeutics.com) develops, manufactures and commercializes therapeutic products and devices intended to promote the repair, protection and healing of bone, cartilage and soft tissue. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible biocompatible /bio·com·pat·i·ble/ (-kom-pat´i-b'l) being harmonious with life; not having toxic or injurious effects on biological function. polymer found throughout the body. Anika products include OrthoVisc(R), a treatment for osteoarthritis osteoarthritis or osteoarthrosis or degenerative joint disease Most common joint disorder, afflicting over 80% of those who reach age 70. It does not involve excessive inflammation and may have no symptoms, especially at first. of the knee available internationally and marketed in the U.S. by Ortho Biotech Products, L.P., and Hyvisc(R), a treatment for equine osteoarthritis marketed in the U.S. by Boehringer Ingelheim Vetmedica, Inc. Anika manufactures Amvisc(TM) and Amvisc Plus(TM), HA viscoelastic Adj. 1. viscoelastic - having viscous as well as elastic properties natural philosophy, physics - the science of matter and energy and their interactions; "his favorite subject was physics" products for ophthalmic surgery. It also produces CoEase(TM), which is marketed by Advanced Medical Optics Advanced Medical Optics, Inc., (NYSE: EYE) (known as AMO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. , Inc., STAARVISC(TM)-II distributed by STAAR STAAR Second Time Around Aussie Rescue, Inc. (Bryan, TX) STAAR Space Technology Applications Astronomy & Rocket Research (Scottish Rocket Programme) Surgical Company and Shellgel(TM) for Cytosol cytosol /cy·to·sol/ (sit´ah-sol) the liquid medium of the cytoplasm, i.e., cytoplasm minus organelles and nonmembranous insoluble components.cytosol´ic cy·to·sol n. Ophthalmics, Inc. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion